Synthesis and in vitro study of antiproliferative benzyloxy dihydropyrimidinones. Issue 6 (15th February 2021)

• Record Type: Journal Article
• Authors: Vala, Ruturajsinh M.; Sharma, Mayank G.; Patel, Divyang M.; Puerta, Adrián; Padrón, José M.; Ramkumar, Venkatachalam; Gardas, Ramesh L.; Patel, Hitendra M.
• Is Part Of: Archiv der Pharmazie. Volume 354:Issue 6(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-02-15
• Subjects: antiproliferative activity -- dihydropyrimidinones -- lanthanum triflate -- Lipinski's rule of five; Pharmaceutical chemistry -- Periodicals; Pharmacology -- Periodicals; 615.19
• DOI: 10.1002/ardp.202000466
• Languages: English
• ISSNs: 0365-6233

Abstract

Abstract: In this study, we report on antiproliferative benzyloxy dihydropyrimidinones (DHPMs) produced by the Biginelli reaction of benzyloxy benzaldehyde, urea, and diverse 1, 3‐diones. The reaction was catalyzed by lanthanum triflate and completed within 1–1.5 h, with 74–97% yield. The antiproliferative assay was carried out for all synthesized dihydropyrimidinones against six human solid tumor cell lines. Six compounds showed good antiproliferative activity with GI50 values below 5 μM. Among all the synthesized compounds, the most potent derivative showed good antiproliferative activity against all cell lines with GI50 values in the range of 1.1–3.1 μM. These DHPMs comply with druglikeness. Furthermore, ADMET prediction and the effect of P‐glycoprotein on the antiproliferative activity were also studied. Overall, our method allows eco‐friendly access to benzyloxy DHPMs as potential anticancer drugs. Abstract : In vitro antiproliferative assays of 20 benzyloxy dihydropymidinones against six solid human tumor cell lines are reported in this study. Among them, six compounds showed good antiproliferative activity with GI50 values below 5 μM. The two most potent compounds, 4p and 4q, were evaluated for drug‐like properties, which comply with the recommended drug properties.